Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/8QQ stock hub

FRA/8QQ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/8QQis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.4B
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/8QQFRA/8QQ
Loading chart…
In the news

Latest news · FRA/8QQ

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-14.5
P25 n/aP50 n/aP75 n/a
ROIC-36.6
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/8QQ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
164
Groups with data
11
Currency
USD
Showing 164 of 164 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Canada
Country code
DE
Employees
562
Employees Change
10%
Employees Change Percent
1.71
Enterprise value
EUR 1B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 1.4B
Price
EUR 4.16
Price currency
EUR
Rev Per Employee
113,855.01x
Sic
2836
Symbol
fra/8QQ
Website
https://www.abcellera.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-9.18%
EV Earnings
-8.24x
EV/FCF
-6.93x
EV/Sales
16.09x
FCF yield
-10.91%
P/B ratio
1.65x
P/S ratio
21.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
EBIT Margin
-288.98%
EBITDA Margin
-259.47%
Gross margin
-148.68%
Gross Profit
EUR -95.1M
Net Income
EUR -124.7M
Pretax Margin
-236.39%
Profit Margin
-194.88%
Profit Per Employee
EUR -221,885
ROA
-9.99
Roa5y
-2.27
ROCE
-16.8
ROE
-14.47
Roe5y
-2.19
ROIC
-36.58
Roic5y
-12.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
134.7%
Cagr3y
-8.59%
Cagr5y
-29.33%
Revenue Growth
160.56x
Revenue Growth Q
788.18x
Revenue Growth3 Y
-46.31x
Revenue Growth5 Y
-20.27x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
EUR 0.06
Assets
EUR 1.2B
Cash
EUR 454.7M
Current Assets
EUR 617.5M
Current Liabilities
EUR 54.5M
Debt
EUR 122M
Debt Equity
EUR 0.15
Debt FCF
EUR -0.82
Equity
EUR 823.5M
Liabilities
EUR 332.2M
Long Term Assets
EUR 538.2M
Long Term Liabilities
EUR 277.7M
Net Cash
EUR 332.7M
Net Cash By Market Cap
EUR 24.48
Net Cash Growth
-30.28%
Net Debt Equity
EUR -0.4
Tangible Book Value
EUR 750.1M
Tangible Book Value Per Share
EUR 2.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
11.32
Net Working Capital
EUR 115.8M
Quick ratio
10.07
Working Capital
EUR 565.5M
Working Capital Turnover
EUR 0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-1.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
134.56%
200-day SMA
3.55
3Y total return
-23.61%
50-day SMA
3.17
50-day SMA vs 200-day SMA
50under200
5Y total return
-82.37%
All Time High
45.1
All Time High Change
-90.78%
All Time High Date
2021-02-02
All Time Low
1.7
All Time Low Change
144.56%
All Time Low Date
2025-04-09
ATR
0.19
Ch YTD
44.44
High
4.16
High52
5.78
High52 Date
2025-10-02
High52ch
-28.03%
Low
4.16
Low52
1.75
Low52 Date
2025-06-02
Low52ch
138.12%
Ma50ch
31.06%
Price vs 200-day SMA
17.28%
RSI
64.45
RSI Monthly
48.15
RSI Weekly
62.11
Sharpe ratio
1.28x
Sortino ratio
2.29
Total Return
-1.49%
Tr YTD
44.44
Tr1m
41.74%
Tr1w
9.19%
Tr3m
66.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -184.9M
Operating margin
-289

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
205,248,101%
Net Borrowing
25,210,758.2
Shares Insiders
22.85%
Shares Institutions
28.47%
Shares Qo Q
0.29%
Shares Yo Y
1.49%
Short Ratio
10.56

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

50
MetricValue
Adjusted FCF
EUR -195.8M
Average Volume
413.4x
Bv Per Share
2.74
CAPEX
EUR -36.4M
Ch1m
41.74
Ch1w
9.19
Ch1y
134.5
Ch3m
66.4
Ch3y
-23.61
Ch5y
-82.37
Ch6m
26.06
Change
-3.14%
Change From Open
0
Close
4.3
Days Gap
-3.14
Depreciation Amortization
18,800,165.5
Earnings Date
2026-05-11
EBIT
EUR -184.9M
EBITDA
EUR -166M
EPS
EUR -0.42
F Score
4
FCF
EUR -148.3M
FCF EV Yield
-14.43x
Financing CF
11,993,639
Fiscal Year End
December
Founded
2,012
Goodwill
40,537,671.4
Income Tax
EUR -26.6M
Investing CF
74,736,675
Is Primary Listing
0
Last Earnings Date
2026-02-24
Last Report Date
2025-12-31
Ma150
3.46
Ma150ch
20.41%
Ma20
3.5
Ma20ch
18.86%
Net CF
-24,159,322
Next Earnings Date
2026-05-11
Open
4.16
Ppne
362,930,279.9
Price Date
2026-05-08
Ptbv Ratio
1.81
Relative Volume
0.01x
Revenue
63,986,518x
SBC By Revenue
74.26x
Share Based Comp
47,518,046
Tax By Revenue
-41.51x
Tr6m
26.06%
Volume
0
Z Score
1.73
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/8QQ pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/8QQ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+134.6%
S&P 500 1Y: n/a
3Y total return
-23.6%
S&P 500 3Y: n/a
5Y total return
-82.4%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/8QQ?

Insider, institutional, and short-interest positioning.

Institutional ownership
+28.5%
Share of float held by funds and institutions
Insider ownership
+22.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
10.6 days to cover
Y/Y dilution
+1.5%
Negative means the company is buying back shares.
Technical

FRA/8QQ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
64.5
Neutral momentum band
Price vs 200-day MA
+17.3%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
1.28
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/8QQ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/8QQ stock rating?

fra/8QQ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/8QQ analysis?

The full report lives at /stocks/fra/8QQ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/8QQ?

The latest report frames fra/8QQ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/8QQ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.